Author: News Room

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In iLearningEngines To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in iLearningEngines between April 22, 2024 and August 28, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Nov. 06, 2024 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against iLearningEngines, Inc. (“iLearningEngines” or…

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Evolv To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Evolv between August 19, 2022 and October 30, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Nov. 06, 2024 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Evolv Technologies Holdings, Inc.…

SALT LAKE CITY, UT, Nov. 06, 2024 (GLOBE NEWSWIRE) — AirLife Utah, part of Air Methods, proudly announces that Pilot Jen Prince and Flight Nurse James Vanotti have been named among the 2024 Utah Business Healthcare Heroes. This esteemed recognition highlights their exceptional commitment to patient care, their lifesaving expertise, and their dedication to strengthening healthcare throughout Utah. “Jen and James exemplify dedication, skill, and compassion, making a profound impact in emergency air medical services across Utah,” said Air Methods CEO JaeLynn Williams. “Every day, they deliver an extraordinary standard of care in emergency air medical services across Utah. They…

All amounts are in United States dollars, unless otherwise stated. TORONTO, Nov. 06, 2024 (GLOBE NEWSWIRE) — Alamos Gold Inc. (TSX:AGI; NYSE:AGI) (“Alamos” or the “Company”) today reported its financial results for the quarter ended September 30, 2024. “We achieved a number of operational and financial records in the third quarter. Production increased to a record 152,000 ounces reflecting the addition of Magino and continued strong performances from Island Gold and Mulatos. With growing gold production and record gold prices, we generated record revenue and cash flow from operations before working capital, supporting strong ongoing free cash flow while funding…

TORONTO, Nov. 06, 2024 (GLOBE NEWSWIRE) — Wallbridge Mining Company Limited (TSX:WM, OTCQB:WLBMF) (“Wallbridge” or the “Company”) today announced the results of the Phase 2 exploration drilling program at its 100% owned Martiniere gold project (“Martiniere”) which returned multiple high grade gold intercepts from three exploration targets along the Bug Lake (“BL”) deformation zone located within 500 metres (“m”) of the currently delineated mineral resource. Highlights Significant high grade gold intercepts returned from the Phase 2 drilling program at Martiniere include: BL North5.78 g/t Au over 3.9 m including 21.56 g/t Au over 0.9 m in hole MR-24-099Horsefly15.63 g/t Au…

IRVINE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its highly anticipated Elevate by Toll Brothers at Great Park Neighborhoods community in Irvine, California, is now open for sale. New home sites have just been released and prospective home buyers can take advantage of pre-model pricing at the Toll Brothers Sales Center located at 105 Apron in Irvine. Elevate by Toll Brothers at Great Park Neighborhoods offers elegant new single-family homes within a spectacular master-planned community in Irvine. These stunning luxury homes are the largest available in the community, offering three…

/ Q3 2024 Results Revenue of $601.9 millionGAAP diluted earnings per share of $1.46 and non-GAAP diluted earnings per share of $2.58GAAP operating profit margin of 26.8% and non-GAAP operating profit margin of 45.8%Operating cash flows of $174.2 million and unlevered operating cash flows of $184.5 millionAnnual contract value (ACV) of $540.5 millionDeferred revenue and backlog of $1,463.8 million on September 30, 2024 PITTSBURGH, Nov. 06, 2024 (GLOBE NEWSWIRE) — ANSYS, Inc. (NASDAQ: ANSS), today reported third quarter 2024 revenue of $601.9 million, an increase of 31% in reported and constant currency when compared to the third quarter of 2023. For…

VANCOUVER, British Columbia, Nov. 06, 2024 (GLOBE NEWSWIRE) — Mustang Energy Corp. (CSE: MEC, OTC: MECPF, FRA: 92T) (the “Company” or “Mustang”) is pleased to announce that it has applied for exploration permits on its Yellowstone and Dutton projects in northern Saskatchewan. The applications, recently submitted to the Saskatchewan Ministry, represent Mustang’s commitment to advancing these uranium projects located within the Athabasca Basin, Saskatchewan. With these permit applications, Mustang aims to initiate exploration activities aimed at further assessing the viability of the projects. In addition to the Yellowstone and Dutton permit applications, Mustang is also expecting imminent exploration permits for its…

Multiple clinical trial milestones were achieved, including encouraging topline data for a Phase 2 trial in CCM, the first patient dosed for a Phase 2 trial in recurrent C. difficile infection, and IND clearance for a Phase 1/2 trial in biomarker-enriched solid tumors and lymphoma (Target RBM39), which highlight a growing number of potential clinical program catalystsOur first neuroscience phenomap was optioned by Roche-Genentech for $30 million as part of a fee structure that could exceed a total of $500 million across multiple maps before program-specific milestones or royaltiesEntered into an expanded collaboration with Google Cloud to leverage technologies to support our…

SALT LAKE CITY, Nov. 06, 2024 (GLOBE NEWSWIRE) — Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended September 30, 2024. “For the third quarter of 2024, I am pleased with our strong financial results, including total revenue of $76.4 million and Adjusted EBITDA of $7.3 million, with these results exceeding the mid-point of our quarterly guidance on each metric. This financial performance continues to demonstrate our ability to scale as we remain focused on driving profitable growth. We are encouraged with…